Riskpilot← Back to searchSign inGet full accessI4HELSE AS
ASActiveOrg 822574742Jon Lilletuns Vei 9, 4879 GrimstadEngineering activities and related technical consultancy · NACE 7112Est. 20192 employees
Revenue 2024
NOK 0
EBITDA margin
—
+88% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
NOK -144K
+88% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -144K | +88% |
| Net profit | NOK -144K | +88% |
| Total assets | NOK 879K | -31% |
| Equity | NOK 867K | -14% |
| Employees | 2 | — |
Legal name
I4HELSE AS
Org number
822574742
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
3. april 2019
Share capital
NOK 5 000 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Aksjeselskap med et ideelt og allmennyttig formål. Formålet er å bidra til innovasjon og produkt /tjenesteutvikling for private og offentlige virksomheter innenfor helse- og sosialsektoren, med spesielt fokus innenfor e-helse. I4helse vil i samarbeid med partnere utvikle og verifisere tjenester og produkter/teknologi, forretnings- og driftskonsepter, samt forestå testing og sertifisering. Selskapet kan starte opp prosjekter i egen regi med mål om å knytte til seg partnere og/eller bidra til spredning av utviklede produkter og tjenester til andre samfunnssektorer. I4helse as har ikke ervervsmessig virksomhet som formål, og selskapets overskudd skal disponeres til det beste for arbeidet med å realisere selskapets formål. Det skal ikke utbetales utbytte til eierne.
Address
Jon Lilletuns Vei 9, 4879 Grimstad
Phone
+4741698998
Email
steinar@i4helse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 101 | 986 | 1 062 | 860 | 488 | 0 |
| Staff expenses | −449 | −1 132 | −1 150 | −1 280 | −1 026 | −3 |
| EBITDA | −475 | −377 | −874 | −1 055 | −1 150 | −144 |
| Depreciation & amort. | −3 | −8 | −8 | −8 | −40 | −0 |
| EBIT | −478 | −386 | −882 | −1 063 | −1 190 | −144 |
| Net financials | 0 | 0 | 7 | 2 | −0 | 0 |
| Profit before tax | −477 | −386 | −875 | −1 061 | −1 190 | −144 |
| Tax | −105 | −0 | −0 | 105 | −0 | −0 |
| Net profit | −372 | −386 | −875 | −1 166 | −1 190 | −144 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 1 072 | 610 | 2 012 | 2 624 | 1 273 | 879 |
| Equity | 628 | 242 | 1 367 | 2 201 | 1 011 | 867 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 445 | 368 | 646 | 423 | 262 | 12 |
| Total debt | 445 | 368 | 646 | 423 | 262 | 12 |
EBITDA margin
-14361300.0%
This company
15.8%
Market median
-90894404% vs market
20192024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20192024
Return on equity
-16.6%
This company
18.4%
Market median
-190% vs market
20192024
Net profit margin
-14357100.0%
This company
8.1%
Market median
-177248248% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IN Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
SO Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Universitetet I Agder | Company | 100.0% | 100.0% | 2023 |
Mechatronics Innovation Lab As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norce Norwegian Research Centre AsNorce Innovation AsMechatronics Innovation Lab As
I4HELSE AS (this company)Board members of I4HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Nilsen Holen | Chief Executive Officer | 0 companies |
| Steinar Olstad Omnes | Chief Executive Officer | 0 companies |
| Mariann Fossum | Board of Directors | 0 companies |
| Grete Dagsvik | Board of Directors | 0 companies |
| Ann Camilla Schulze-Krogh | Chairman | 0 companies |
| Kjetil Hellang | Board of Directors | 0 companies |
| Anna Camilla Mattsdotter Bruno Dunsæd | Board of Directors | 0 companies |
| Hans Kjetil Lysgård | Board of Directors | 0 companies |
| Ann Camilla Krogh | Chairman | 0 companies |
| Even Krogstad | Board of Directors | 0 companies |
| Margunn Aanestad | Board of Directors | 0 companies |
| Tor Asbjørn Aagedal | Chairman | 0 companies |
| Petter Natanael Toldnæs | Board of Directors | 0 companies |
| Jon Harald Kaspersen | Board of Directors | 0 companies |